梅州双眼皮修复的哪里好梅州怀孕多长时间适合流产,梅州隆鼻大约要多少钱,梅州细菌阴道炎严重吗,梅州做打胎多少价钱,梅州怀孕49天能做人流吗,梅州咨询怎样治疗阴道炎,梅州做鼻子哪家好

NEWPORT BEACH, Calif. (AP) — Prosecutors added criminal charges involving five additional victims Wednesday in the case of a California surgeon and his girlfriend who were previously charged with drugging and sexually assaulting two women.The Orange County district attorney's office said the additional charges include kidnapping and rape by use of drugs.The new charges accuse Dr. Grant Robicheaux of sexually assaulting five additional women. His girlfriend, Cerissa Riley, is now charged in three additional assaults. Details were not immediately released.Robicheaux, 38, and Riley, 31, appeared in court and pleaded not guilty to all counts. A judge ordered their bail to be raised to million each, up from 0,000 each.Robicheaux once appeared in a reality TV show called "Online Dating Rituals of the American Male."When the pair was originally charged last month, prosecutors said they received leads to more than a dozen possible additional victims.Authorities said the two initial victims met Robicheaux and Riley at social events in Southern California, where they became intoxicated and ended up at Robicheaux's apartment.Robicheaux could now face a term of more than 82 years to life in prison if convicted. Riley could face 63 years to life in prison if convicted.Both had friends and family who walked up and hugged them during a break in the courtroom proceedings. During a bail discussion, Riley turned to see them in the gallery and fought back tears. Afterward, she cried in the courtroom while being hugged by supporters."Thanks for coming," she said.___Associated Press reporter John Antczak contributed to this report from Los Angeles. 1669

NEW YORK — An influential scientific panel on Tuesday voted to recommend to the CDC that when a COVID-19 vaccine becomes available, both front line health care workers and residents in long-term care facilities should be prioritized first. The Advisory Committee on Immunization Practices voted 14-1 in favor of adopting the following recommendation: When a COVID-19 vaccine is authorized by FDA and recommended by ACIP, vaccination in the initial phase of the COVID-19 vaccination program (Phase 1a) should be offered to both 1) health care personnel and 2) residents of long-term care facilities.Watch the meeting live here."About one (American) dies every minute from COVID-19. During this ACIP meeting, about 120 people will die," Dr. Beth Bell said during initial remarks at the beginning of the virtual meeting Tuesday.The ACIP met Tuesday afternoon in an open-to-the-public, virtual meeting to vote on the proposal that gives priority to health care workers and patients in nursing homes and other long-term care facilities. The two groups together represent around 23 million Americans out of a population of about 330 million; about 21 million in health care professions and less than 3 million adults living in long-term care facilities.Current estimates project around 40 million doses combined available by the end of 2020. And each vaccine product requires two doses.The CDC said Tuesday they expect 5-to-10 million doses available each week after a vaccine is authorized by the FDA. They say these numbers necessitate the need for sub-group prioritizing, since not all health care workers or long-term care facilities can be vaccinated at once. Another consideration the panel discussed is not having an entire unit or group get vaccinated at once; if there are side effects like fatigue or other symptoms that necessitates taking a day or two off, this could leave a unit critically short-staffed. During Tuesday's presentation, Dr. Kathleen Dooling talked about statistics from COVID-19 patients in the US and how it lead to health care workers and long-term facility staff and patients to be at the top of the vaccine list. Long-term care facilities are responsible for six percent of COVID-19 cases and 40 percent of COVID-19 deaths in this country, she said. Later this month, the Food and Drug Administration will consider approval of two vaccines made by Pfizer and Moderna. The panel meeting Tuesday said they hope to learn more about the safety and effectiveness of the vaccines as more information is released by the FDA.Dr. Dooling said one of the questions they hope to ask about the Phase 3 trial data of both Pfizer and Moderna is how effective one dose of the vaccine has shown to be. They will also be taking a deeper look at the age groups of those included in the trial, and the efficacy of the vaccines on older people. Some of the comments during the public comment section referenced the lack of transparency released at this time about the vaccines and the panel trying to make vaccination decisions without it. However, the panel, while voting, expressed faith in the FDA's process of approving the vaccine as safe for all Americans. Once vaccines are given, the CDC and FDA will be asking all health care providers and facilities to use the existing Vaccine Adverse Event Reporting System, VAERS, to monitor any side effects and adverse reactions to the COVID-19 vaccines. The advisory panel will meet again at some point to decide who should be next in line. Among the possibilities: teachers, police, firefighters and workers in other essential fields such as food production and transportation; the elderly; and people with underlying medical conditions.Experts say the vaccine will probably not become widely available in the U.S. until the spring.ACIP is a 15-member panel of outside scientific experts, created in 1964, that makes recommendations to the director of the Centers for Disease Control and Prevention, who almost always approves them. Childhood vaccine schedules are one example of the work of this group. The recommendations are not binding, but for decades they have been widely heeded by doctors, and they have determined the scope and funding of U.S. vaccination programs.It will be up to state authorities whether to follow the guidance. It will also be left to them to make further, more detailed decisions if necessary — for example, whether to put emergency room doctors and nurses ahead of other health care workers if vaccine supplies are low. 4517

NEW YORK — David Dinkins, the first Black mayor of New York City, died Monday at the age of 93.Dinkins was elected in 1989 and served as mayor from 1990 to 1993, making him the first and only Black man to serve as the city's mayor.He was born in 1927 in Trenton, New Jersey. He was drafted, served as a Marine and later graduated from Howard University and Brooklyn Law School. He served in the state assembly before later becoming president of the board of elections, a city clerk and Manhattan borough president.Dinkins defeated longtime incumbent Mayor Ed Koch in the Democratic primary in 1989 and later beat Rudy Giuliani on his path to City Hall.In his inaugural address, he vowed to be "mayor of all the people of New York" and declared, "we are all foot soldiers on the march to freedom."Dinkins was known for his reserved public demeanor and civility.He was an American voice in favor of anti-apartheid sanctions, and his policies as mayor reflected his support for South Africa.He also created the office of Special Commissioner of Investigations for schools, built a system of after hour youth centers called Beacon Schools, and worked to create an all civilian police complaint review board.According to a city biography, Dinkins was sharply criticized for his handling of racial strife in Crown Heights, a boycott of Korean Grocers in Brooklyn and civil unrest in Washington Heights. He also dealt with sluggish economic growth.Giuliani succeeded Dinkins in 1993 after one term in office.After leaving City Hall, Dinkins remained active in city politics and taught public affairs at Columbia University.The NYPD said initial indications were that he died of natural causes.Dinkins was married to his wife Joyce for more than 65 years, and together they had two children.Joyce Dinkins died in October. She was 89.This story was originally published by Corey Crockett, John Muller on WPIX in New York City. The Associated Press contributed to this report. 1974

NEWWARK, N.J. – OxyContin maker Purdue Pharma has pleaded guilty to three criminal charges and formally admitted its role in the opioid crisis.Tuesday's plea before a judge in Newark, New Jersey, is part of a larger settlement with the U.S. Department of Justice that also includes resolving civil claims.The Stamford, Connecticut-based company is to pay 5 million as part of the deal, while billion in forfeitures and penalties could be waived because of a proposed deal to resolve thousands of other lawsuits.Advocates are upset that the guilty plea applies only to the company and not executives or members of the Sackler family who own it.During Tuesday’s hearing, Purdue Pharma admitted to impeding the US. Drug Enforcement’s efforts to combat the addiction crisis and acknowledged it paid doctors to induce them to write more prescriptions for its painkillers.More than 750,000 people have died from drug overdoses since 1999, according to the Centers for Disease Control and Prevention (CDC).The CDC says two out of three overdose deaths in 2018 involved opioid, which are substances that work in the nervous system of the body or in specific receptors in the brain to reduce the intensity of pain.Since 1999, the CDC says overdose deaths involving opioid like prescription drugs and heroin have increased six times. 1337

NEW: Supreme Court lets Trump administration end census count early. No explanation given. Sotomayor dissents.— Greg Stohr (@GregStohr) October 13, 2020 166